Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:49 AM UTC
| NCT Number | NCT06679101 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 520 participants |
| Active Locations | 30 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | April 22, 2026 (Apr 22, 2026) |
As of October 16, 2026: Clinical trial NCT06679101 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 30 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06679101 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06679101 was last updated Apr 22, 2026 (April 22, 2026). HelloStudys verifies this status automatically.